Abstract
Modelling of the mechanism of covalent adduct formation by the inhibitor O-arylcarbamate URB524 in FAAH shows that only one of the two possible inhibitor binding orientations is consistent with the experimentally observed irreversible carbamoylation of the nucleophile serine: this is a potentially crucial insight for designing new covalent inhibitors of this promising drug target.
Original language | English |
---|---|
Pages (from-to) | 214-216 |
Journal | Chemical Communications |
Volume | 2008 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2008 |
Keywords
- Fatty acids
- Inhibitors
- Chemical